Discover 3,557 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,557
Neostigmine Route for Acute Colonic Pseudo Obstruction
for
Ogilvie Syndrome
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 16+
Code: NCT04951726
Recruiting
Pharmacogenomics of Asparaginase Induced Hepatotoxicity
for
Acute Lymphoblastic Leukemia
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT03568266
Recruiting
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
Get alerts for new trials in your area by subscribing now
Duration of Urinary Catheterization
for
Colorectal Surgery
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT04359069
Recruiting
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
for
Localized Prostate Carcinoma,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Male
Age: 55 - 70+
Code: NCT06500169
Recruiting
Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
for
Clonal Cytopenia of Undetermined Significance,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06063486
Phase2, Recruiting
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
for
Chronic Myelogenous Leukemia - Chronic Phase
Location: Torrance CA, Stockton CA, Salem OR, Tacoma WA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07091019
Recruiting
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
for
Advanced Alveolar Soft Part Sarcoma,
Location: Los Angeles CA, Oklahoma City OK, Houston TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05333458
Phase2, Recruiting
Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
for
Advanced NUT Carcinoma, Metastatic NUT Carcinoma,
Location: Los Angeles CA, Houston TX, Pittsburgh PA, Boston MA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05019716
Phase1, Phase2, Recruiting
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Los Angeles CA, La Jolla CA, Salt Lake City UT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05896839
Phase1, Phase2, Recruiting
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
for
Acute Treatment of Migraine
Location: Los Angeles CA, Canoga Park CA, Austin TX, Dallas TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07609914
Recruiting
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
for
Prostate Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Male
Age: 18+
Code: NCT06067295
Recruiting
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
for
Non-small Cell Lung Cancer (NSCLC)
Location: Glendale CA, San Francisco CA, Arlington VA, Edison NJ
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07566052
Phase3, Recruiting
fNIRS for Disorders of Consciousness
for
Disorders of Consciousness Due to Severe Brain Injury,
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18+
Code: NCT07485361
Recruiting
Postpartum NSAIDS and Maternal Hypertension
for
Preeclampsia, Gestational Hypertension,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Female
Age: 18+
Code: NCT03824119
Recruiting
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)